bibliographic entry 8105531 [be/8105531]
https://w3id.org/oc/corpus/be/8105531

is a

• bibliographic reference

content

• Richardson PG, Jagannath S, Moreau P, Jakubowiak A, Raab MS, Facon T et al. Final results for the 1703 phase 1b/2 study of elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma. Blood 2014; 124: 302.

references

• https://w3id.org/oc/corpus/br/75763